awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28077848-BC41CCB2-C159-4713-87DD-F1B36C3B7679
Q28077848-BC41CCB2-C159-4713-87DD-F1B36C3B7679
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077848-BC41CCB2-C159-4713-87DD-F1B36C3B7679
Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays
P2860
Q28077848-BC41CCB2-C159-4713-87DD-F1B36C3B7679
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28077848-BC41CCB2-C159-4713-87DD-F1B36C3B7679
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc9d876c9c52efde2851c379929fcefa659572ab
P2860
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.